- RecruitingPHASE2
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
This study is looking at a new medicine called zasocitinib for adults with Crohn's disease. Researchers want to understand how it works and if it's safe. It involves taking the medicine for 3 months and having tests, including a bowel examination, to see its effects.
For: Crohn's DiseaseUnited Kingdom - RecruitingPHASE3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
This study looks at a new drug, zasocitinib, for adults with psoriatic arthritis. It aims to see how well it works compared to a dummy drug. We're interested in people who have or haven't tried certain other treatments before.
For: Psoriatic ArthritisUnited States · Argentina · Australia - RecruitingPHASE3
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
This study looks at a new medicine called zasocitinib for children and teenagers aged 4-17 with moderate-to-severe plaque psoriasis. It aims to understand how well it works and if it's safe over a long period. Some participants will receive a placebo at first.
For: Plaque PsoriasisUnited States · China · Germany